Check out the latest in aging advances, research, and events happening at NIA:
- NIA study identifies FDA-approved drugs that may also be helpful for dementia — An innovative new study, led by NIA researchers, seeks to determine whether drugs shown to be safe and effective for treating conditions other than dementia can be repurposed to help prevent or treat Alzheimer’s disease.
- Could reducing cardiovascular risk in early adulthood be key to keeping cognition later? — A new study, funded in part by NIA, showed that risk factors such as elevated body mass index, fasting glucose, and systolic blood pressure were associated with poorer cognitive health later in life.
- NIH scientists try a new twist on using ‘personalized’ stem cells for studying dementia — Researchers will create and evaluate a new set of more than 100 induced pluripotent stem cell (iPSC) lines, each line of the same genetic background and carrying a different mutation known to cause Alzheimer’s disease and related dementias.
- Nerve cell biomarker helps predict mortality risk in older-age adults — Levels of a nerve cell protein called neurofilament light chain (NfL) more accurately predict remaining lifespan in late life than estimates based on physical and cognitive function which are currently used, according to a study supported in part by NIA.
- How stress causes hair loss — Researchers examined the role of the adrenal glands, which produce key stress hormones, on hair regrowth throughout the lifespan and its effects on hair follicle stem cells in mice.
- Mitochondrial health is linked to longer life in female rats with high exercise capacity — A research team including scientists at NIA found that healthy mitochondria may help protect the aging heart in female rats with high treadmill running capacity.
- One year of rapid acceleration of diagnostics, and anticipating new challenges — Leaders across NIH reflect on the work of the Rapid Acceleration of Diagnostics (RADx) initiative and discuss plans for the future, representing a unified effort to meet the testing-related challenges presented by the COVID-19 pandemic with excellence and innovation.
Read more of the latest NIA research news in the NIA newsroom.
Related posts:
Studies Recruiting Healthy Volunteers and People With Mild Cognitive Impairment or Dementia
Diet May Affect Risk of Sudden Cardiac Death; the Link Between Cholesterol and Dementia Risk; and, New Tool for Clinical Trial Recruitment
Viagra Associated With Reduced Risk of Alzheimer’s; Ritalin and Apathy in Alzheimer’s; and Brainstem Changes May Detect Alzheimer’s Earlier